West Pharmaceutical Services Inc. (WST) News

West Pharmaceutical Services Inc. (WST): $328.94

-6.09 (-1.82%)

POWR Rating

Component Grades













Filter WST News Items

WST News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

WST News Highlights

  • For WST, its 30 day story count is now at 5.
  • Over the past 26 days, the trend for WST's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • DRUG, HSIC and MMSI are the most mentioned tickers in articles about WST.

Latest WST News From Around the Web

Below are the latest news stories about WEST PHARMACEUTICAL SERVICES INC that investors may wish to consider to help them evaluate WST as an investment opportunity.

13 Best Monthly Dividend Stocks to Buy According to Analysts

In this article, we discuss 13 best monthly dividend stocks to buy according to analysts. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Monthly Dividend Stocks to Buy According to Analysts. In 2022, dividends remained a bright spot for investors, despite a stock market […]

Yahoo | March 20, 2023

HSIC or WST: Which Is the Better Value Stock Right Now?

HSIC vs. WST: Which Stock Is the Better Value Option?

Yahoo | March 13, 2023

West Announces Second-Quarter 2023 Dividend

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a second-quarter 2023 dividend of $0.19 per share. The dividend will be paid on May 3, 2023, to shareholders of record as of April 26, 2023.

Yahoo | March 3, 2023

MMSI vs. WST: Which Stock Is the Better Value Option?

MMSI vs. WST: Which Stock Is the Better Value Option?

Yahoo | February 23, 2023

Does West Pharmaceutical Services (WST) Have a Long Runway for Growth?

Baron Funds, an investment management company, released its “Baron Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund gained 11.93% (Institutional Shares) compared to a 4.13% return for the Russell 2000 Growth Index and a 7.56% return for the S&P 500 Index. Favourable […]

Yahoo | February 22, 2023

West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Call Transcript February 16, 2023 Operator: Good day, and thank you for standing by. Welcome to West Pharmaceutical Services Fourth Quarter 2022 Earnings Conference Call. . I would now like to hand the conference over to your speaker today, Quintin Lai, Vice President, Investor Relations. Please go […]

Yahoo | February 20, 2023

West Pharmaceutical Services Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

West Pharmaceutical Services ( NYSE:WST ) Full Year 2022 Results Key Financial Results Revenue: US$2.89b (up 2.0% from...

Yahoo | February 18, 2023

Analyst Views West Pharmaceutical's Q4 Earnings Impressive Despite Headwinds

West Pharmaceutical Services Inc (NYSE: WST) reported Q4 2022 net sales of $708.7 million, down 3%, and organic net sales growth was 2.6%, beating the consensus of $657.17 million. Q4 adjusted EPS of $1.77 fell 13.2% but beat the consensus of $1.38. COVID revenue was approximately $86 million for the quarter, and it now expects COVID contributions of $85 million for the next year as part of its 2023 guidance. EPS guidance of $7.25-$7.40 for 2023 was ahead of the Street ($7.27) and far better tha

Yahoo | February 16, 2023

West Pharmaceutical (WST) Q4 Earnings Beat, Order Book Strong

West Pharmaceutical's (WST) fourth-quarter results reflect sustained growth in non-COVID-19 demand amid dismal overall performance.

Yahoo | February 16, 2023

West Pharmaceutical Services (WST) Q4 Earnings and Revenues Beat Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of 27.34% and 8.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 16, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6416 seconds.